Comparison of Postoperative Outcomes between Leadless and Conventional Transvenous Pacemakers Implantation: An Up-to-Date Meta-analysis.

IF 16.4 1区 化学 Q1 CHEMISTRY, MULTIDISCIPLINARY Accounts of Chemical Research Pub Date : 2024-10-09 eCollection Date: 2024-10-01 DOI:10.31083/j.rcm2510359
Huimiao Dai, Hao Liu, Chuncheng Gao, Jing Han, Jun Meng, Pengyun Liu, Mingming Zhang, Dongdong Li, Wangang Guo
{"title":"Comparison of Postoperative Outcomes between Leadless and Conventional Transvenous Pacemakers Implantation: An Up-to-Date Meta-analysis.","authors":"Huimiao Dai, Hao Liu, Chuncheng Gao, Jing Han, Jun Meng, Pengyun Liu, Mingming Zhang, Dongdong Li, Wangang Guo","doi":"10.31083/j.rcm2510359","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Leadless cardiac pacemakers (LCPs) are emerging as viable alternatives to conventional transvenous pacemakers (TVPs). This study aimed to systematically compare the postoperative outcomes of LCPs and TVPs based on available published studies.</p><p><strong>Methods: </strong>We conducted a systematic review and meta-analysis of literature comparing outcomes from LCP and TVP implantations. Data analysis was performed using Stata/MP 17.0. The evaluated endpoints included pericardial effusion or perforation, puncture site events, infective endocarditis, lead or device dislodgement, pocket-related complications, tricuspid regurgitation or dysfunction, any infection, increased right ventricle (RV) pacing threshold, embolism, and thrombosis. Aggregated odds ratios (OR) and 95% confidence intervals (CI) were determined. Sensitivity analyses were conducted for heterogeneity if I<sup>2</sup> was >50% or <i>p</i> < 0.01, otherwise, the random-effects model was chosen. Publication bias was analyzed if the number studies exceeded ten.</p><p><strong>Results: </strong>The meta-analysis included 24 observational studies with 78,938 patients, comprising 24,191 with LCP implantation and 54,747 with TVP implantation. The results indicated a significantly lower incidence of lead or device dislodgment (OR = 3.32, 95% CI: 1.91-5.77, <i>p</i> < 0.01), infective endocarditis (OR = 3.62, 95% CI: 3.10-4.24, <i>p</i> < 0.01), and infection (OR = 3.93, 95% CI: 1.67-9.24, <i>p</i> < 0.01) in the LCP group compared to the TVP group. In contrast, incidences of puncture site complications (OR = 0.24, 95% CI: 0.19-0.32, <i>p <</i> 0.01) and pericardial effusion or perforation (OR = 0.33, 95% CI: 0.28-0.39, <i>p</i> < 0.01) were significantly higher in the LCP group.</p><p><strong>Conclusions: </strong>Compared with TVP, LCP implantation is associated with a lower risk of infective endocarditis, lead or device dislodgment, infections, and pocket-related complications. However, LCP implantation carries a higher risk of puncture site complications and pericardial effusion or perforation. These findings underscore the need for careful consideration of patient-specific factors when choosing between LCP and TVP implantation.</p><p><strong>The prospero registration: </strong>https://www.crd.york.ac.uk/prospero/ (CRD42023453145).</p>","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":null,"pages":null},"PeriodicalIF":16.4000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11522773/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.31083/j.rcm2510359","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Leadless cardiac pacemakers (LCPs) are emerging as viable alternatives to conventional transvenous pacemakers (TVPs). This study aimed to systematically compare the postoperative outcomes of LCPs and TVPs based on available published studies.

Methods: We conducted a systematic review and meta-analysis of literature comparing outcomes from LCP and TVP implantations. Data analysis was performed using Stata/MP 17.0. The evaluated endpoints included pericardial effusion or perforation, puncture site events, infective endocarditis, lead or device dislodgement, pocket-related complications, tricuspid regurgitation or dysfunction, any infection, increased right ventricle (RV) pacing threshold, embolism, and thrombosis. Aggregated odds ratios (OR) and 95% confidence intervals (CI) were determined. Sensitivity analyses were conducted for heterogeneity if I2 was >50% or p < 0.01, otherwise, the random-effects model was chosen. Publication bias was analyzed if the number studies exceeded ten.

Results: The meta-analysis included 24 observational studies with 78,938 patients, comprising 24,191 with LCP implantation and 54,747 with TVP implantation. The results indicated a significantly lower incidence of lead or device dislodgment (OR = 3.32, 95% CI: 1.91-5.77, p < 0.01), infective endocarditis (OR = 3.62, 95% CI: 3.10-4.24, p < 0.01), and infection (OR = 3.93, 95% CI: 1.67-9.24, p < 0.01) in the LCP group compared to the TVP group. In contrast, incidences of puncture site complications (OR = 0.24, 95% CI: 0.19-0.32, p < 0.01) and pericardial effusion or perforation (OR = 0.33, 95% CI: 0.28-0.39, p < 0.01) were significantly higher in the LCP group.

Conclusions: Compared with TVP, LCP implantation is associated with a lower risk of infective endocarditis, lead or device dislodgment, infections, and pocket-related complications. However, LCP implantation carries a higher risk of puncture site complications and pericardial effusion or perforation. These findings underscore the need for careful consideration of patient-specific factors when choosing between LCP and TVP implantation.

The prospero registration: https://www.crd.york.ac.uk/prospero/ (CRD42023453145).

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
无引线和传统经静脉起搏器植入术的术后效果比较:最新的 Meta 分析。
背景:无引线心脏起搏器(LCP)正在成为传统经静脉起搏器(TVP)的可行替代品。本研究旨在根据已发表的研究结果,系统比较 LCP 和 TVP 的术后效果:我们对比较 LCP 和 TVP 植入术后效果的文献进行了系统回顾和荟萃分析。数据分析使用 Stata/MP 17.0 进行。评估的终点包括心包积液或穿孔、穿刺部位事件、感染性心内膜炎、导联或装置脱落、袋相关并发症、三尖瓣反流或功能障碍、任何感染、右心室起搏阈值升高、栓塞和血栓形成。确定了综合几率比(OR)和 95% 置信区间(CI)。如果I2>50%或P<0.01,则进行异质性敏感性分析,否则选择随机效应模型。如果研究数量超过十项,则对发表偏倚进行分析:荟萃分析包括24项观察性研究,共78938名患者,其中24191名患者植入了LCP,54747名患者植入了TVP。结果显示,与 TVP 组相比,LCP 组的导联或装置脱落(OR = 3.32,95% CI:1.91-5.77,p <0.01)、感染性心内膜炎(OR = 3.62,95% CI:3.10-4.24,p <0.01)和感染(OR = 3.93,95% CI:1.67-9.24,p <0.01)发生率明显较低。相比之下,LCP组穿刺部位并发症(OR=0.24,95% CI:0.19-0.32,P 0.01)和心包积液或穿孔(OR=0.33,95% CI:0.28-0.39,P <0.01)的发生率明显更高:结论:与 TVP 相比,LCP 植入术发生感染性心内膜炎、导联或装置脱落、感染和袋相关并发症的风险较低。但是,LCP 植入术发生穿刺部位并发症、心包积液或穿孔的风险较高。这些发现强调,在选择 LCP 还是 TVP 植入术时,需要仔细考虑患者的具体因素。prospero 注册:https://www.crd.york.ac.uk/prospero/ (CRD42023453145)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Accounts of Chemical Research
Accounts of Chemical Research 化学-化学综合
CiteScore
31.40
自引率
1.10%
发文量
312
审稿时长
2 months
期刊介绍: Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance. Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.
期刊最新文献
Management of Cholesteatoma: Hearing Rehabilitation. Congenital Cholesteatoma. Evaluation of Cholesteatoma. Management of Cholesteatoma: Extension Beyond Middle Ear/Mastoid. Recidivism and Recurrence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1